News

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...
Managed Healthcare Executive6d

Teva Launches First Generic GLP-1 Drug for Obesity

Teva Pharmaceuticals has received FDA approval and has launched a generic version of Saxenda (liraglutide), which is approved to treat adults and adolescents 12 to 17 years of age who are obese or ...
Nasdaq1y

Teva Announces Launch of Authorized Generic of Victoza ... - Nasdaq

Liraglutide injection may affect the way some medicines work and some medicines may affect the way liraglutide injection works.
Insider Monkey on MSN4d

Teva Pharmaceutical Industries (TEVA) Announces the FDA Approval and U.S. Launch of Generic Saxenda

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy growth stocks to buy now. On August 28, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced the FDA approval ...
NJBIZ1d

Teva wins FDA nod for first generic GLP-1 weight-loss drug

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.
MedPage Today on MSN7d

First Generic GLP-1 Injection OK'd for Weight Loss

The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva ...
The Pharma Letter2d

Teva to offer first US generic GLP-1 specifically for weight loss

Israeli drugmaker Teva Pharmaceutical Industries has announced US Food and Drug Administration (FDA) approval and launch of a ...

Did FDA Approval of Generic Saxenda Just Shift Teva's (TEVA) Investment Narrative?

Teva Pharmaceuticals announced in late August 2025 that it received FDA approval and commenced the U.S. launch of its generic version of Saxenda® (liraglutide injection), which had annual sales of ...
Medical Dialogues6d

USFDA approves Teva Pharma generic Saxenda for weight loss

Parsippany: Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced the FDA approval and U.S. launch of a generic version of Saxenda ...
The American Journal of Managed Care8mon

FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

Liraglutide injection was initially approved for adults with type 2 diabetes in 2010, with an expanded indication in 2019 including children and adolescents aged 10 to 17 years. 2 It was the first ...
Investing.com India6d

Teva stock rises on launch of first generic weight loss GLP-1 drug

Investing.com -- Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) stock rose 2.7% after the company announced FDA approval and U.S. launch of its generic version of Saxenda (liraglutide injection), ...
McKnight's Long-Term Care News8mon

FDA approves first generic liraglutide once-daily injection

The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve ...